Comparison of cefoxitin and ceftizoxime in a hospital therapeutic interchange program

Martinusen, Shelagh; Chen, Dan; Frighetto, Luciana; Bunz, Donna; Stiver, H. Grant; Jewesson, Peter J.
April 1993
CMAJ: Canadian Medical Association Journal;4/1/1993, Vol. 148 Issue 7, p1161
Academic Journal
No abstract available.


Related Articles

  • Experience briefs.  // Formulary;Apr96, Vol. 31 Issue 4, p304 

    Presents successful clinical outcomes and cost savings associated with a 12-hour IV ceftizoxime regimen. Clinical indications approved for the ceftizoxime for ceftriaxone therapeutic interchange program; Ceftizoxime use at Charlton Memorial Hospital from May, 1994 to April, 1995; Dosage...

  • Experience briefs.  // Formulary;Mar1996, Vol. 31 Issue 3, p221 

    Presents the results of the evaluation of a ceftizoxime (Cefizox) to ceftriaxone (Rocephin) therapeutic interchange program for patients with uncomplicated community-acquired pneumonia. Adverse effects; Impact on duration of confinement in the hospital and routine discharge rates; Mortality;...

  • Automatic interchange of the ACE inhibitors: Decision-making process and initial results. Stoysich, Anne; Massoomi, Fred // Formulary;Jan2002, Vol. 37 Issue 1, p41 

    Examines the oral angiotensin converting enzyme (ACE) inhibitors as the target for an automatic therapeutic interchange (ATI) program. Goal of the ATI program; Selection of three oral ACE inhibitors for inclusion on the hospital formulary; Adverse effects associated with ACE inhibitors. INSET:...

  • Cost savings from a midazolam to lorazepam therapeutic interchange program.  // Formulary;Sep98, Vol. 33 Issue 9, p905 

    Discusses cost savings realized by the Thomas Jefferson University Hospital in Philadelphia, Pennsylvania from using a midazolam to lorazepam therapeutic interchange program. Interchange process; Educational processes; Implementation.

  • Superior discriminative performance of ceftizoxime disk diffusion test for detecting meticillin-resistant Staphylococcus aureus. Wagenvoort, J.; Ciraci, V.; Penders, R.; Gronenschild, J.; Brauwer, E.; Goessens, W. // European Journal of Clinical Microbiology & Infectious Diseases;Jun2006, Vol. 25 Issue 6, p405 

    The article discusses a study on the performance of ceftizoxime and cefoxitin disks for rapid surrogate screening for methicillin resistance in Staphylococcus aureus (MRSA). For ceftizoxime, superior discrimination was achieved with the addition of sodium chloride at both 30 and 37 degree...

  • Survey of hospital policies regarding low-molecular-weight heparins. Schumock, Glen T.; Nutescu, Edith A.; Walton, Surrey M.; Arondekar, Bhakti V.; Lewis, Richard K. // American Journal of Health-System Pharmacy;3/15/2002, Vol. 59 Issue 6, p1 

    Analyzes the hospital policies on the use of low-molecular-weight heparins (LMWH) in the U.S. Use of prescribing guidelines; Programs for therapeutic interchange; Policies to promote alternatives to LMWH.

  • Prevalence and cost savings of therapeutic interchange among U.S.hospitals. Schachtner, Jill M.; Guharoy, Roy; Medicis, Joseph J.; Newman, Nancy; Speizer, Ronald // American Journal of Health-System Pharmacy;3/15/2002, Vol. 59 Issue 6, p1 

    Examines the prevalence and cost savings of therapeutic interchange among teaching, non-teaching and investor-owned hospitals in the U.S. Formulary management; Individuals involved in decision-making process for therapeutic interchange policies; Percentage of hospitals reporting use of...

  • Evaluation of selection media for the detection of borderline MRSA. Yamada, Keiko; Inuzuka, Kazuhisa; Tatsumi, Norio; Sanzen, Ikuyo; Ohkura, Teruko; Okamoto, Akira; Hasegawa, Tadao; Ohta, Michio // Journal of Infection & Chemotherapy (Springer Science & Business;Feb2010, Vol. 16 Issue 1, p19 

    Recently, hospital-associated as well as community-acquired methicillin-resistant Staphylococcus aureus (MRSA) strains showing a low level of resistance to oxacillin have emerged worldwide, and as a result, a highly sensitive method to detect MRSA has become more important. To prevent MRSA being...

  • Optimizaci�n de la prescripci�n electr�nica asistida: aumentar la seguridad del intercambio terap�utico y conciliaci�n de medicamentos. Gim�nez Poder�s, T.; Pila Rodr�guez, D.; Valero Dom�nguez, M.; Ferr�ndiz Gos�lbez, J. R. // El Farmac�utico Hospitales;dic2011, Issue 198, p5 

    The therapeutic exchange considers the existence of medications clinically equivalent and interchangeable among each other , and defines which is the most adequate prescription according to the patient, and based on the hospital medication policy. The guides of therapeutic interchange have been...

  • Outcomes of an Erythropoietic Growth Factor Interchange Program in Hospitalized Chronic Hemodialysis Patients. Mohammad, Rima A.; Sweet, Burgunda V.; Mueller, Bruce A.; Perlman, Rachel L.; Stevenson, James G. // Hospital Pharmacy;Feb2007, Vol. 42 Issue 2, p119 

    Background: The substantial cost of erythropoietic growth factors (EGFs), darbepoetin alfa and epoetin alfa, has led many institutions to evaluate EGF usage and costs in the hospital setting. The primary objectives of this study were to determine the clinical impact on hemoglobin (Hb)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics